IP Library › Assignment 054393/0695
Patent Assignment
Reel/Frame 054393/0695

Assignment of Assignor's Interest

Recorded: 2020-11-12 Pages: 18
Assignor
Assignee
THERAVANCE BIOPHARMA R&D IP, LLC
901 GATEWAY BLVD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (51)
Biphenyl derivatives
Application: 11/788,343 →
Publication: US 2007/0208176
Biphenyl derivatives useful for treating pulmonary disorders
Application: 60/447,843 →
Biphenyl derivatives useful for treating pulmonary disorders
Application: 60/467,035 →
Crystalline form of a biphenyl compound
Application: 60/601,805 →
Diamide Compounds Having Muscarinic Receptor Antagonist and BETA2 Adrenergic Receptor Agonist Activity
Application: 16/774,024 →
Publication: US 2020/0165223
Diamide Compounds Having Muscarinic Receptor Antagonist and BETA2 Adrenergic Receptor Agonist Activity
Application: 61/172,039 →
Crystalline Oxalate Salts of a Diamide Compound
Application: 61/388,148 →
Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
Application: 60/794,702 →
Crystalline form of a biphenyl derivative
Application: 60/544,621 →
Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Application: 12/412,194 →
Publication: US 2009/0182010
Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
Application: 60/601,781 →
Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
Application: 60/601,779 →
Crystalline Forms of a Dimethylphenyl Compound
Application: 12/970,013 →
Publication: US 2011/0086881
Crystalline forms of a dimethylphenyl compound
Application: 60/794,709 →
Biphenyl Derivatives
Patent: 7,141,671 →
Application: 10/779,157 →
Publication: US 2004/0167167
Biphenyl Derivatives
Patent: 7,879,879 →
Application: 11/448,317 →
Publication: US 2006/0223860
Biphenyl Derivatives
Patent: 7,355,046 →
Application: 11/448,294 →
Publication: US 2006/0223859
Biphenyl Derivatives
Patent: 7,345,175 →
Application: 11/448,293 →
Publication: US 2006/0223858
Biphenyl Derivatives
Patent: 7,521,561 →
Application: 11/449,004 →
Publication: US 2006/0229334
Biphenyl Derivatives
Patent: 7,524,959 →
Application: 11/582,885 →
Publication: US 2007/0037984
Biphenyl Derivatives
Patent: 7,514,558 →
Application: 11/604,607 →
Publication: US 2007/0088054
Biphenyl Derivatives
Patent: 7,829,583 →
Application: 11/879,004 →
Publication: US 2007/0276003
Biphenyl Derivatives
Patent: 7,507,751 →
Application: 11/888,526 →
Publication: US 2008/0015220
Biphenyl Derivatives
Patent: 8,242,135 →
Application: 13/011,100 →
Publication: US 2011/0312994
Biphenyl Derivatives
Patent: 8,618,131 →
Application: 13/545,523 →
Publication: US 2013/0150404
Biphenyl Derivatives
Patent: 8,969,571 →
Application: 14/087,404 →
Publication: US 2014/0235864
Crystalline Form of a Biphenyl Compound
Patent: 7,521,558 →
Application: 11/204,065 →
Publication: US 2006/0035931
Crystalline Form of a Biphenyl Compound
Patent: 8,101,766 →
Application: 12/369,605 →
Publication: US 2009/0221638
Crystalline Form of a Biphenyl Compound
Patent: 8,476,299 →
Application: 13/328,386 →
Publication: US 2012/0283289
Crystalline Form of a Biphenyl Compound
Patent: 8,754,223 →
Application: 13/910,708 →
Publication: US 2013/0289281
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta-2 Adrenergic Receptor Agonist Activity
Patent: 8,138,345 →
Application: 12/761,532 →
Publication: US 2010/0273755
Diamide Compounds Having Muscarinic Receptor Antagonist and BETA2 Adrenergic Receptor Agonist Activity
Patent: 8,551,978 →
Application: 13/369,109 →
Publication: US 2013/0137665
Diamide Compounds Having Muscarinic Receptor Antagonist and BETA2 Adrenergic Receptor Agonist Activity
Patent: 8,816,088 →
Application: 13/964,484 →
Publication: US 2013/0331364
Diamide Compounds Having Muscarinic Receptor Antagonist and BETA2 Adrenergic Receptor Agonist Activity
Patent: 9,000,173 →
Application: 14/327,853 →
Publication: US 2014/0323733
Diamide Compounds Having Muscarinic Receptor Antagonist and BETA2 Adrenergic Receptor Agonist Activity
Patent: 9,394,275 →
Application: 14/638,171 →
Publication: US 2015/0274697
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity
Patent: 9,572,802 →
Application: 15/180,165 →
Publication: US 2016/0361304
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity
Patent: 9,682,957 →
Application: 15/379,673 →
Publication: US 2017/0096412
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity
Patent: 9,771,350 →
Application: 15/497,446 →
Publication: US 2017/0226082
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity
Patent: 9,975,875 →
Application: 15/680,323 →
Publication: US 2017/0362200
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity
Application: 15/959,549 →
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity
Application: 16/159,829 →
Publication: US 2019/0047984
Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity
Application: 16/434,220 →
Publication: US 2019/0300504
Crystalline Oxalate Salts of a Diamide Compound
Patent: 8,697,724 →
Application: 13/248,840 →
Publication: US 2012/0083478
Dialkylphenyl Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 7,524,965 →
Application: 11/789,300 →
Publication: US 2007/0249675
Dialkylphenyl Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 7,687,521 →
Application: 12/406,283 →
Publication: US 2009/0176833
Dialkylphenyl Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 8,134,006 →
Application: 12/701,108 →
Publication: US 2010/0137603
Crystalline Form of a Biphenyl Compound
Patent: 7,320,990 →
Application: 11/057,009 →
Publication: US 2005/0182092
Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 7,528,253 →
Application: 11/204,066 →
Publication: US 2006/0116398
Compounds Having Beta Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 7,569,586 →
Application: 11/204,263 →
Publication: US 2006/0035933
Method of Using Compounds Having Beta-2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 8,143,277 →
Application: 12/479,017 →
Publication: US 2009/0239904
Crystalline Forms of a Dimethylphenyl Compound
Patent: 7,880,010 →
Application: 11/789,154 →
Publication: US 2007/0249674
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 29, 2003
From: MAMMEN, MATHAI
To: THERAVANCE, INC.
Reel/Frame 013613/0308 →
Assignment of Assignor's Interest Jun 13, 2003
From: MAMMEN, MATHAI; DUNHAM, SARAH; HUGHES, ADAM; LEE, TAE WEON
To: THERAVANCE, INC.
Reel/Frame 013756/0355 →
Assignment of Assignor's Interest May 4, 2004
From: MAMMEN, MATHAI; DUNHAM, SARAH; HUGHES, ADAM; LEE, TAE WEON
To: THERAVANCE, INC.
Reel/Frame 014595/0853 →
Assignment of Assignor's Interest May 14, 2004
From: CHAO, ROBERT; RAPTA, MIROSLAV; COLSON, PIERRE-JEAN; LEE, JUNNING
To: THERAVANCE, INC.
Reel/Frame 014632/0155 →
Assignment of Assignor's Interest Oct 28, 2004
From: CHAO, ROBERT; RAPTA, MIROSLAV; COLSON, PIERRE-JEAN
To: THERAVANCE, INC.
Reel/Frame 015309/0382 →
Assignment of Assignor's Interest Nov 11, 2004
From: MAMMEN, MATHAI; MISCHKI, TREVOR
To: THERAVANCE, INC.
Reel/Frame 015372/0294 →
Assignment of Assignor's Interest Nov 11, 2004
From: MAMMEN, MATHAI; MISCHKI, TREVOR
To: THERAVANCE, INC.
Reel/Frame 015372/0152 →
Assignment of Assignor's Interest May 19, 2005
From: CHEN, YAN
To: THERAVANCE, INC.
Reel/Frame 016584/0463 →
Assignment of Assignor's Interest Sep 9, 2005
From: CHEN, YAN
To: THERAVANCE, INC.
Reel/Frame 016767/0175 →
Assignment of Assignor's Interest Aug 29, 2006
From: COLSON, PIERRE-JEAN; HUGHES, ADAM D.; HUSFELD, CRAIG; MAMMEN, MATHAI
To: THERAVANCE, INC.
Reel/Frame 018187/0974 →
Assignment of Assignor's Interest Sep 5, 2006
From: BOLTON, JENNIFER; CHAO, ROBERT S.; RAPTA, MIROSLAV; WILLIAMS, LISA
To: THERAVANCE, INC.
Reel/Frame 018232/0743 →
Assignment of Assignor's Interest Oct 21, 2009
From: HUGHES, ADAM; BYUN, DANIEL; CHEN, YAN; FLEURY, MELISSA
To: THERAVANCE, INC.
Reel/Frame 023405/0551 →
Assignment of Assignor's Interest Nov 1, 2010
From: RAPTA, MIROSLAV; THALLADI, VENKAT; CHAO, ROBERT S.
To: THERAVANCE, INC.
Reel/Frame 025224/0979 →
Assignment of Assignor's Interest Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE RESPIRATORY COMPANY, LLC
Reel/Frame 033175/0547 →
Assignment of Assignor's Interest Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE RESPIRATORY COMPANY, LLC
Reel/Frame 033175/0620 →
Assignment of Assignor's Interest Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE RESPIRATORY COMPANY, LLC
Reel/Frame 033175/0676 →
Assignment of Assignor's Interest Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE RESPIRATORY COMPANY, LLC
Reel/Frame 033178/0558 →
Assignment of Assignor's Interest Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE RESPIRATORY COMPANY, LLC
Reel/Frame 033178/0721 →
Assignment of Assignor's Interest Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE RESPIRATORY COMPANY, LLC
Reel/Frame 033178/0658 →
Assignment of Assignor's Interest Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE RESPIRATORY COMPANY, LLC
Reel/Frame 033175/0490 →
Assignment of Assignor's Interest Jul 23, 2014
From: THERAVANCE, INC.
To: THERAVANCE RESPIRATORY COMPANY, LLC
Reel/Frame 033371/0626 →